Search results
Showing 346 to 360 of 8905 results
This guideline covers general principles for prescribing and managing withdrawal from opioids, benzodiazepines, gabapentinoids, Z-drugs and antidepressants in primary and secondary care.
Hyperparathyroidism (primary): diagnosis, assessment and initial management (NG132)
This guideline covers diagnosing, assessing and managing primary hyperparathyroidism. It aims to improve recognition and treatment of this condition, reducing long-term complications and improving quality of life.
This guideline covers the routine antenatal care that women and their babies should receive. It aims to ensure that pregnant women are offered regular check-ups, information and support.
In development Reference number: GID-QS10197 Expected publication date: 27 February 2026
All NICE products on ovarian cancer. Includes any guidance, advice and quality standards.
All NICE products on metastases. Includes any guidance, advice and quality standards.
All NICE products on acute coronary syndromes. Includes any guidance, advice and quality standards.
All NICE products on stable angina. Includes any guidance, advice and quality standards.
All NICE products on structural heart defects. Includes any guidance and advice.
All NICE products on hypertension. Includes any guidance and quality standards.
All NICE products on vasculitis. Includes any guidance.
All NICE products on adrenal dysfunction. Includes any guidance.
All NICE products on eye conditions. Includes any guidance, advice and quality standards.
All NICE products on pancreatitis. Includes any guidance and advice.
All NICE products on prostate cancer. Includes any guidance, advice and quality standards.